Search Results 761-770 of 16993 for monoclonal antibody

1. A Study to Determine Number of Rounds of Plasma Exchange Needed to Decrease Measles Virus Antibodies for Measles Virus Cancer Therapy - Mayo Clinic

   The purpose of this study is to determine how many rounds of plasma exchange are required for maximal decrease in measles antibodies and how long it may last, ...

2. Treating Highly Sensitized Patients on the Kidney Transplant Waiting List by Depleting Their B-cells Using Chimeric Antigen Receptor T Cells (CAR-T) - Mayo Clinic

   Any patients who received a desensitization therapy including any monoclonal antibodies, plasmapheresis, and/or splenectomy; Inability to understand and sign ...

3. A Study of Pembrolizumab Alone or Combined with CC-486 for Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer - Mayo Clinic

   Prior treatment with a monoclonal antibody within 4 weeks prior to ... Known or suspected hypersensitivity to monoclonal antibodies; Currently ...

4. A Study of JNJ-68284528, a Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Monoclonal antibody treatment for multiple myeloma within 21 days;; Cytotoxic therapy within 14 days;; Proteasome inhibitor therapy within 14 days ...

5. Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence - Mayo Clinic

   History of severe hypersensitivity reaction to any monoclonal antibody. Prior malignancy active within the previous 3 years except for locally potentially ...

6. Squamous Cell Carcinoma Of The Skin Clinical Trials - Mayo Clinic Research

   Monoclonal antibodies, such as pembrolizumab, may block tumor growth in different ways by targeting certain cells. Drugs used in chemotherapy, such as cisplatin ...

7. Myeloma, Amyloidosis, Dysproteinemia Group - Overview - Mayo Clinic

   Monoclonal gammopathy-associated conditions including C1-esterase inhibitor deficiency, cryoglobulinemia, osteosclerotic myeloma, peripheral neuropathy ...

8. Selective IgA deficiency - Symptoms and causes - Mayo Clinic

   An immunoglobulin is an antibody produced by immune system cells to fight bacteria, parasites and other agents that cause illness. IgA antibodies circulate ...

9. Coronavirus Disease 2019 (COVID-19) Clinical Trials - Mayo Clinic Research

   ... antibody detectable targets on cancer cells (cancer vaccines or antibody ... Monoclonal Antibodies to Treat Hospitalized Patients with COVID-19 Rochester, MN.

10. Testing the Addition of an Anti-cancer Drug, ASTX727, to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast Cancer - Mayo Clinic

    Patients who have received prior PD-1/PD-L1 monoclonal antibodies in any disease setting are eligible. ... antibody agent, ASTX727 is a hypomethylating ...